A Phase I Study Of The Novel Dna Topoisomerase-1 Inhibitor, Tlc388, Administered Intravenously To Patients With Advanced Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2011)